MINERALYS THERAPEUTICS INC (MLYS:NASDAQ)
$25.89 -0.45 (-1.7084%)
Analysed MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) News Sources
What to Know About This Mineralys Insider Sale Before a December FDA Date
16-07-2026
fool.com
A Mineralys Insider Banked a $557,000 Options Gain Before a December FDA Date
16-07-2026
fool.com
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
27-07-2026
yahoo.com
Mineralys Therapeutics (MLYS) Heads Into Earnings As Lorundrostat Hopes Meet Undervalued View
05-08-2026
yahoo.com
Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
11-08-2026
yahoo.com
Mineralys Therapeutics Q2 Earnings Call Highlights
11-08-2026
marketbeat.com
Mineralys Therapeutics Inc (MLYS) (Q2 2026) Earnings Call Highlights: Strong Cash Position and ...
12-08-2026
yahoo.com
Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
13-08-2026
yahoo.com
Mineralys (MLYS) Q2 2026 Earnings Call Transcript
18-08-2026
fool.com
Mineralys Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference
26-08-2026
yahoo.com
What is the current price of MINERALYS THERAPEUTICS INC (MLYS:NASDAQ)?
The current price of MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) is $25.89.
MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) absolute price change since previous trading day?
The absolute price change of MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) since the previous trading day is $-0.45.
MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) percentage price change since previous trading day?
The percentage price change of MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) since the previous trading day is -1.7084%.
What is the most recent average sentiment score for MINERALYS THERAPEUTICS INC (MLYS:NASDAQ)?
The most recent average sentiment score for MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for MINERALYS THERAPEUTICS INC (MLYS:NASDAQ)?
The most recent sentiment for MINERALYS THERAPEUTICS INC (MLYS:NASDAQ) is .
SEC-8K** Filing Available For MINERALYS THERAPEUTICS INC (MLYS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.